Provided herein are heterocyclic compounds for treatment of CSFIR, FLT3, KIT, and/or PDGFRbeta kinase mediated diseases. Also provided are pharmaceutical compositions comprising the compounds and methods of using the compounds and compositions.
申请公布号
WO2013056070(A2)
申请公布日期
2013.04.18
申请号
WO2012US59983
申请日期
2012.10.12
申请人
AMBIT BIOSCIENCES CORPORATION
发明人
HADD, MICHAEL J.;HOCKER, MICHAEL D.;HOLLADAY, MARK W.;LIU, GANG;ROWBOTTOM, MARTIN W.;XU, SHIMIN
